@article{APS10413,
author = {Hai-feng Hu and Zeng Ye and Yi Qin and Xiao-wu Xu and Xian-jun Yu and Qi-feng Zhuo and Shun-rong Ji},
title = {Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications},
journal = {Acta Pharmacologica Sinica},
volume = {42},
number = {11},
year = {2021},
keywords = {},
abstract = {Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers, with a minimal difference between its incidence rate and mortality rate. Advances in oncology over the past several decades have dramatically improved the overall survival of patients with multiple cancers due to the implementation of new techniques in early diagnosis, therapeutic drugs, and personalized therapy. However, pancreatic cancers remain recalcitrant, with a 5-year relative survival rate of },
issn = {1745-7254}, url = {http://www.chinaphar.com/article/view/10413}
}